Loading organizations...
§ Private Profile · Seattle, WA, USA
Ex vivo expanded universal donor cellular therapies for cancer treatment.
Nohla Therapeutics has raised $127.4M across 5 funding rounds.
Nohla Therapeutics has raised $127.4M in total across 5 funding rounds.
Nohla Therapeutics has raised $127.4M in total across 5 funding rounds.
Nohla Therapeutics's investors include Premier Partners, Schroder Adveq, University of Tokyo Edge Capital, Celgene, Fidelity Management & Research Company, 5AM Ventures, Alexandria Venture Investments, AML Biotech Partners, ARCH Venture Partners, California Institute for Regenerative Medicine, Steven Gillis, Brian Daniels.
Nohla Therapeutics has raised $127.4M across 5 funding rounds. Most recently, it raised $11.0M Series B Extension in July 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 12, 2018 | $11M Series B Plus | — | Premier Partners, Schroder Adveq, University OF Tokyo Edge Capital | Announced |
| May 16, 2018 | $45M Series B | Celgene, Fidelity Management & Research Company | 5AM Ventures, Alexandria Venture Investments, AML Biotech Partners, ARCH Venture Partners | Announced |
| Sep 28, 2017 | $6.9M Grant | California Institute For Regenerative Medicine | — | Announced |
| Nov 30, 2016 | $43.5M Series A | Steven Gillis | Brian Daniels, Jagen Group | Announced |
| Dec 24, 2015 | $21M Venture Round | — | — | Announced |